Opus Genetics IRD Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's preferred stock, shares authorized?
- Opus Genetics (IRD) reported preferred stock, shares authorized of $2.63M in Q1 2026.
- How has Opus Genetics's preferred stock, shares authorized changed year-over-year?
- Opus Genetics's preferred stock, shares authorized decreased by 73.7% year-over-year, from $9.99M to $2.63M.
- What is the long-term trend for Opus Genetics's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Opus Genetics's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $10M to $10M.